Market Size of Global Antiemetic Drugs Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.30 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Antiemetic Drugs Market Analysis
The antiemetic drugs market is expected to register a CAGR of 6.3% over the forecast period, 2022-2027.
The COVID-19 pandemic has had a positive impact on the antiemetic drugs market. The increased cases of SARS-CoV-2 have boosted the use of antiemetics to treat nausea and vomiting induced by COVID-19 or any other medication. For instance, in a study titled "Current Knowledge and recent advances in Intracellular Emetic Signaling System" published in The International Journal of Clinical Practice, 2021, it was observed that the use of antiemetics was severely increased during COVID-19 to treat nausea and vomiting. According to the same source, it was also used in hospitalized COVID-19 patients who might be undergoing open surgery and therefore more prone to nausea and vomiting. Thus, the COVID-19 outbreak positively impacted the antiemetic drug market's growth.
In addition, the increasing prevalence of cancer and gastroenteritis worldwide, the surge in research and development activities, and the identification of new drug targets have been positively affecting the growth of the studied market.
As chemotherapy and gastroenteritis treatments are linked with nausea and vomiting as major adverse effects, antiemetics are an important treatment regimen used in these procedures. According to the data published by the International Agency of Research for Cancer, the global cancer burden is estimated to be 19.3 million new cases, which implies one in five people worldwide develops cancer during their lifetime. For both sexes, the incidence was 2-to-3-fold higher in transitioned nations than in developing nations. As chemotherapy is one of the most widely used treatment protocols for cancer, the adoption of antiemetics is likely to bolster among the patient population as it is accompanied by adverse side effects such as nausea and vomiting. Furthermore, a research study titled "Antiemetic drugs: what to prescribe and when" published in the National Library of Medicine in April 2020 suggested that antiemetics are used in indications like gastroenteritis and chemotherapy-induced nausea and vomiting. These factors are collectively anticipated to drive the demand for antiemetics among cancer and gastroenteritis patients.
Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, less awareness about antiemetic drugs among the population is likely to impede the market's growth.
